1. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591-1601. doi:10.1002/mds.26424
2. Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R. Value of in vivo α-synuclein deposits in Parkinson’s disease: A systematic review and meta-analysis. Mov Disord. 2019;34(10):1452-1463. doi:10.1002/mds.27794
3. Lim S-Y, Tan AH, Ahmad-Annuar A, et al. Parkinson’s disease in the Western Pacific Region. Lancet Neurol. 2019;18(9):865-879. doi:10.1016/S1474-4422(19)30195-4
4. Velseboer DC, de Bie RMA, Wieske L, et al. Development and external validation of a prognostic model in newly diagnosed Parkinson disease. Neurology. 2016;86(11):986-993. doi:10.1212/WNL.0000000000002437
5. Bekkers EMJ, Dijkstra BW, Dockx K, Heremans E, Verschueren SMP, Nieuwboer A. Clinical balance scales indicate worse postural control in people with Parkinson’s disease who exhibit freezing of gait compared to those who do not: A meta-analysis. Gait Posture. 2017;56:134-140. doi:10.1016/j.gaitpost.2017.05.009
6. Kim R, Lee J, Kim H-J, et al. CSF β-amyloid42 and risk of freezing of gait in early Parkinson disease. Neurology. 2019;92(1):e40-e47. doi:10.1212/WNL.0000000000006692
7. Feustel AC, MacPherson A, Fergusson DA, Kieburtz K, Kimmelman J. Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease. Neurology. 2020;94(1):e1-e14. doi:10.1212/WNL.0000000000008699
8. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology. 2011;77(3):288-294. doi:10.1212/WNL.0b013e318225ab66
9. Ahlskog JE. Aerobic Exercise: Evidence for a Direct Brain Effect to Slow Parkinson Disease Progression. Mayo Clin Proc. 2018;93(3):360-372. doi:10.1016/j.mayocp.2017.12.015
10. Schenkman M, Moore CG, Kohrt WM, et al. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018;75(2):219-226. doi:10.1001/jamaneurol.2017.3517
11. van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: a double-blind, randomised controlled trial. Lancet Neurol. 2019;18(11):998-1008. doi:10.1016/S1474-4422(19)30285-6
12. Mak MK, Wong-Yu IS, Shen X, Chung CL. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol. 2017;13(11):689-703. doi:10.1038/nrneurol.2017.128
13. Rafferty MR, Schmidt PN, Luo ST, et al. Regular Exercise, Quality of Life, and Mobility in Parkinson’s Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data. J Parkinsons Dis. 2017;7(1):193-202. doi:10.3233/JPD-160912
14. Paul KC, Chuang Y-H, Shih I-F, et al. The association between lifestyle factors and Parkinson’s disease progression and mortality. Mov Disord. 2019;34(1):58-66. doi:10.1002/mds.27577
15. Oguh O, Eisenstein A, Kwasny M, Simuni T. Back to the basics: regular exercise matters in parkinson’s disease: results from the National Parkinson Foundation QII registry study. Parkinsonism Relat Disord. 2014;20(11):1221-1225. doi:10.1016/j.parkreldis.2014.09.008
16. Amara AW, Chahine L, Seedorff N, et al. Self-reported physical activity levels and clinical progression in early Parkinson’s disease. Parkinsonism Relat Disord. 2019;61:118-125. doi:10.1016/j.parkreldis.2018.11.006
17. Kim R, Park S, Yoo D, Jun J-S, Jeon B. Association of Physical Activity and APOE Genotype With Longitudinal Cognitive Change in Early Parkinson Disease. Neurology. 2021;96(19):e2429-e2437. doi:10.1212/WNL.0000000000011852
18. Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 2011;95(4):629-635. doi:10.1016/j.pneurobio.2011.09.005
19. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46(2):153-162. doi:10.1016/0895-4356(93)90053-4
20. Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52(7):643-651. doi:10.1016/s0895-4356(99)00049-9
21. Harada ND, Chiu V, King AC, Stewart AL. An evaluation of three self-report physical activity instruments for older adults. Med Sci Sports Exerc. 2001;33(6):962-970. doi:10.1097/00005768-200106000-00016
22. Factor SA, Bennett A, Hohler AD, Wang D, Miyasaki JM. Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary. Neurology. 2016;86(24):2278-2283. doi:10.1212/WNL.0000000000002670
23. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-2170. doi:10.1002/mds.22340
24. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale. Mov Disord. 2013;28(5):668-670. doi:10.1002/mds.25383
25. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. doi:10.1111/j.1532- 5415.2005.53221.x
26. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability. The Clinical Neuropsychologist. 1998;12(1):43-55. doi:10.1076/clin.12.1.43.1726
27. Crowe SF. Does the letter number sequencing task measure anything more than digit span? Assessment. 2000;7(2):113-117. doi:10.1177/107319110000700202
28. Hinton-Bayre A, Geffen G. Comparability, reliability, and practice effects on alternate forms of the Digit Symbol Substitution and Symbol Digit Modalities tests. Psychol Assess. 2005;17(2):237-241. doi:10.1037/1040- 3590.17.2.237
29. Yesavage JA, Sheikh JI. Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. Clinical Gerontologist. 1986;5(1-2):165-173. doi:10.1300/J018v05n01_09
30. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord. 2004;19(11):1306-1312. doi:10.1002/mds.20153
31. Johns MW. A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep. 1991;14(6):540-545. doi:10.1093/sleep/14.6.540
32. Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Mov Disord. 2007;22(16):2386-2393. doi:10.1002/mds.21740
33. Dal Bello-Haas V, Klassen L, Sheppard MS, Metcalfe A. Psychometric Properties of Activity, SelfEfficacy, and Quality-of-Life Measures in Individuals with Parkinson Disease. Physiother Can. 2011;63(1):47-57. doi:10.3138/ptc.2009-08
34. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649-2653. doi:10.1002/mds.23429
35. Bates D, Mächler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. J Stat Soft. 2015;67(1). doi:10.18637/jss.v067.i01
36. Schielzeth H, Dingemanse NJ, Nakagawa S, et al. Robustness of linear mixed-effects models to violations of distributional assumptions. Sutherland C, ed. Methods Ecol Evol. 2020;11(9):1141-1152. doi:10.1111/2041- 210X.13434
37. Rosenbaum PR, Rubin DB. Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score. The American Statistician. 1985;39(1):33. doi:10.2307/2683903
38. Ho DE, Imai K, King G, Stuart EA. MatchIt: Nonparametric Preprocessing for Parametric Causal Inference. J Stat Soft. 2011;42(8). doi:10.18637/jss.v042.i08
39. Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S84-S90.e1. doi:10.1016/j.jclinepi.2013.01.013
40. Shen X, Mak MKY. Technology-assisted balance and gait training reduces falls in patients with Parkinson’s disease: a randomized controlled trial with 12-month follow-up. Neurorehabil Neural Repair. 2015;29(2):103-111. doi:10.1177/1545968314537559
41. Wallén MB, Hagströmer M, Conradsson D, Sorjonen K, Franzén E. Long-term effects of highly challenging balance training in Parkinson’s disease-a randomized controlled trial. Clin Rehabil. 2018;32(11):1520- 1529. doi:10.1177/0269215518784338
42. Radder DLM, Lígia Silva de Lima A, Domingos J, et al. Physiotherapy in Parkinson’s Disease: A MetaAnalysis of Present Treatment Modalities. Neurorehabil Neural Repair. 2020;34(10):871-880. doi:10.1177/1545968320952799
43. Ihle A, Oris M, Fagot D, et al. Associations of educational attainment and cognitive level of job with old age verbal ability and processing speed: The mediating role of chronic diseases. Appl Neuropsychol Adult. 2018;25(4):356-362. doi:10.1080/23279095.2017.1306525
44. Sanchez-Luengos I, Balboa-Bandeira Y, Lucas-Jiménez O, Ojeda N, Peña J, Ibarretxe-Bilbao N. Effectiveness of Cognitive Rehabilitation in Parkinson’s Disease: A Systematic Review and Meta-Analysis. J Pers Med. 2021;11(5):429. doi:10.3390/jpm11050429
45. Schootemeijer S, van der Kolk NM, Ellis T, et al. Barriers and Motivators to Engage in Exercise for Persons with Parkinson’s Disease. J Parkinsons Dis. 2020;10(4):1293-1299. doi:10.3233/JPD-202247
46. Lau B, Meier N, Serra G, et al. Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation. Neurology. 2019;92(22):e2559-e2570. doi:10.1212/WNL.0000000000007562
47. Rowsell A, Ashburn A, Fitton C, et al. Participant expectations and experiences of a tailored physiotherapy intervention for people with Parkinson’s and a history of falls. Disabil Rehabil. Published online June 2020:1-9. doi:10.1080/09638288.2020.1779824
48. Ellis TD, Cavanaugh JT, DeAngelis T, et al. Comparative Effectiveness of mHealth-Supported Exercise Compared With Exercise Alone for People With Parkinson Disease: Randomized Controlled Pilot Study. Phys Ther. 2019;99(2):203-216. doi:10.1093/ptj/pzy131
49. Zhang X, Speakman JR. Genetic Factors Associated With Human Physical Activity: Are Your Genes Too Tight To Prevent You Exercising? Endocrinology. 2019;160(4):840-852. doi:10.1210/en.2018-00873
50. Iwaki H, Blauwendraat C, Leonard HL, et al. Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. Neurol Genet. 2019;5(4):e348. doi:10.1212/NXG.0000000000000348